Hormone replacement therapy and breast cancer risk: more evidence for risk stratification?

J Natl Cancer Inst. 2013 Sep 18;105(18):1342-3. doi: 10.1093/jnci/djt239. Epub 2013 Sep 3.

Authors

Mary Beth Terry¹, Parisa Tehranifar

Affiliation

¹ Affiliations of authors: Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY; and Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY (MBT, PT).

PMID: 24003038
DOI: 10.1093/jnci/djt239

No abstract available

Publication types

Editorial
Comment

MeSH terms

Body Mass Index*
Breast / pathology*
Breast Neoplasms / ethnology*
Breast Neoplasms / etiology*
Estrogen Replacement Therapy / adverse effects*
Female
Humans
Racial Groups*

Grants and funding